12
Views
9
CrossRef citations to date
0
Altmetric
Intra-Arterial Hepatic Chemotherapy, New Drugs and Angiographically Placed Port-a-Cath

Unresectable Hilar Cholangiocarcinoma: Multimodality Treatment with Percutaneous and Intraluminal Plus External Radiotherapy

, , , , , & show all
Pages 55-57 | Published online: 27 Oct 2016

References

  • Bismuth H, Malt RA. Carcinoma of the biliary tract. N Eng J Med 1979; 331: 704–706.
  • Righi D, Maass J, Zanon E et al. Trattamento percutaneo del colangiocarcinoma ilare completato con brachiterapia con alto rateo di dose. Radiol Med 1994; 88: 79–85.
  • Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241–256.
  • Kamada T, Saitou H, Takamura A et al. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiation Oncology Biol Phys 1996; 34: 767–774.
  • Kuvshinoff BW, Armstrong JG, Fong Y et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995; 82: 1522–1525.
  • Karani J, Fletcher M, Brinkley D et al. Internal biliary drainage and local radiotherapy with Ir-192 wire in treatment of hilar cholangiocarcinoma. Clin Radiol 1985; 36: 603–606.
  • Leung J, Guiney M, Das R. Intraluminal brachytherapy in bile duct carcinomas. Aust N Z J Surg 1996; 66(2): 74–7.
  • Milella M, Salvetti M, Cerrotta A et al. Interventional radiology and radiotherapy for inoperable cholangiocarcinoma of the extrahepatic bile ducts. Tumori 1998; 84 (4): 467–71.
  • Gonzalez Gonzalez D, Gouma DJ, Rauws EAJ, et al. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma. Ann Oncol 1999; 10(suppl. 4): 215–220.
  • Golfieri R, Giampalma E, Muzzi C et al. Unresectable hilar cholangiocarcinoma: combined percutaneous and radiotherapic treatment. Radiol Med 2001;101(6):495–502.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.